Our team also demonstrated that inhibiting AKT/GSK3β attenuated pressure overload‐induced myocardial fibrosis and blocked cardiac fibroblasts activation and transformation in vitro (Yan et al., 2011). The gene discussed is AKT1; the disease is Myocardial fibrosis.